When launching the Abbott HIV-1 Assay - the only one capable of detecting and quantifying all known HIV-1 subtypes - we needed to convince lab managers of its value, especially in areas where certain subtypes were considered rare. This arresting campaign put a face on the different subtypes, dramatizing just how widespread and threatening they actually are. Our message was irrefutable: in the fight against AIDS, everyone counts. And only one test counts all subtypes.